180 related articles for article (PubMed ID: 8167717)
1. Analysis of X-chromosome inactivation in bone marrow precursors from carriers of Wiskott-Aldrich syndrome and X-linked severe combined immunodeficiency: evidence that the Wiskott-Aldrich gene is expressed prior to granulocyte-macrophage colony-forming-unit.
Mantuano E; Candotti F; Giliani S; Parolini O; Lusardi M; Zucchi M; Lanfranchi A; Porta F; Airò P; Albertini A
Immunodeficiency; 1993; 4(1-4):271-6. PubMed ID: 8167717
[No Abstract] [Full Text] [Related]
2. Carrier detection in X-linked immunodeficiencies. II: An X inactivation assay based on differential methylation of a line-1 repeat at the DXS255 locus.
Hinds H; Craig IW; Chen ZY; Kraakman ME; Schuurman RK; Hendriks RW
Immunodeficiency; 1993; 4(1-4):213-5. PubMed ID: 8167703
[TBL] [Abstract][Full Text] [Related]
3. Carrier detection in X-linked immunodeficiencies. I: A PCR-based X chromosome inactivation assay at the MAOA locus.
Hendriks RW; Chen ZY; Hinds H; Schuurman RK; Craig IW
Immunodeficiency; 1993; 4(1-4):209-11. PubMed ID: 8167702
[TBL] [Abstract][Full Text] [Related]
4. X chromosome inactivation patterns in leucocyte populations of female carriers of Wiskott-Aldrich syndrome with an atypical presentation.
de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
Immunodeficiency; 1993; 4(1-4):267-9. PubMed ID: 8167716
[No Abstract] [Full Text] [Related]
5. Molecular genetic analysis of X-linked immunodeficiencies.
Conley ME
Year Immunol; 1993; 7():162-7. PubMed ID: 8372504
[No Abstract] [Full Text] [Related]
6. X-linked Wiskott-Aldrich syndrome in a girl.
Luzzatto L; Martini G
N Engl J Med; 1998 Jun; 338(25):1850-1. PubMed ID: 9634368
[No Abstract] [Full Text] [Related]
7. X-linked Wiskott-Aldrich syndrome in a girl.
Parolini O; Ressmann G; Haas OA; Pawlowsky J; Gadner H; Knapp W; Holter W
N Engl J Med; 1998 Jan; 338(5):291-5. PubMed ID: 9445409
[No Abstract] [Full Text] [Related]
8. Patterns of X chromosome inactivation in haematopoietic cells of female carriers of X linked severe combined immunodeficiency.
Hendriks RW; Kraakman ME; Schuurman RK
Immunodeficiency; 1993; 4(1-4):263-5. PubMed ID: 8167715
[TBL] [Abstract][Full Text] [Related]
9. The Wiskott-Aldrich syndrome.
Peacocke M; Siminovitch KA
Semin Dermatol; 1993 Sep; 12(3):247-54. PubMed ID: 8105860
[TBL] [Abstract][Full Text] [Related]
10. X inactivation in females with X-linked disease.
Puck JM; Willard HF
N Engl J Med; 1998 Jan; 338(5):325-8. PubMed ID: 9445416
[No Abstract] [Full Text] [Related]
11. X-linked Wiskott-Aldrich syndrome in a girl.
Cazzola M; Bergamaschi G
N Engl J Med; 1998 Jun; 338(25):1850; author reply 1851. PubMed ID: 9634367
[No Abstract] [Full Text] [Related]
12. [Molecular genetics of X-linked primary immunodeficiencies: advances in diagnosis and prevention].
Carbonara A; Brusco A; Carbonara C
Ann Ital Med Int; 1996; 11(3):180-6. PubMed ID: 8998263
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
Itoh S; Nonoyama S; Morio T; Imai K; Okawa H; Ochs HD; Shimadzu M; Yata J
Int J Hematol; 2000 Jan; 71(1):79-83. PubMed ID: 10729999
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Wiskott-Aldrich syndrome by analysis of the X chromosome inactivation patterns in maternal leucocyte populations using the hypervariable DXS255 locus.
Hendriks RW; De Weers M; Mensink RG; Kraakman ME; Mollee-Versteegde IF; Veerman AJ; Sandkuyl LA; Schuurman RK
Clin Exp Immunol; 1991 May; 84(2):219-22. PubMed ID: 1709069
[TBL] [Abstract][Full Text] [Related]
15. Prenatal diagnosis and genetic analysis of X-linked immunodeficiency disorders.
Puck JM
Pediatr Res; 1993 Jan; 33(1 Suppl):S29-33; discussion S33-4. PubMed ID: 8433872
[TBL] [Abstract][Full Text] [Related]
16. X chromosome linked immunodeficiency.
Schwaber J; Rosen FS
Immunodefic Rev; 1990; 2(3):233-51. PubMed ID: 1981831
[TBL] [Abstract][Full Text] [Related]
17. X-linked thrombocytopenia and Wiskott-Aldrich syndrome: similar regional assignment but distinct X-inactivation pattern in carriers.
De Saint-Basile G; Schlegel N; Caniglia M; Le Deist F; Kaplan C; Lecompte T; Piller F; Fischer A; Griscelli C
Ann Hematol; 1991 Aug; 63(2):107-10. PubMed ID: 1912030
[TBL] [Abstract][Full Text] [Related]
18. The primary immunodeficiencies.
Rosen FS; Cooper MD; Wedgwood RJ
N Engl J Med; 1995 Aug; 333(7):431-40. PubMed ID: 7616993
[No Abstract] [Full Text] [Related]
19. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins.
Huang MM; Tsuboi S; Wong A; Yu XJ; Oh-Eda M; Derry JM; Francke U; Fukuda M; Weinberg KI; Kohn DB
Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of X-linked polymorphic loci as gene markers to track X allele and chimerism in a post-allogeneic peripheral blood stem cell transplant patient with Wiskott-Aldrich syndrome.
Sasanakul W; Hongeng S; Chuansumrit A; Chaiyaratana W; Pakakasama S; Hathirat P
J Med Assoc Thai; 2001 Mar; 84(3):379-84. PubMed ID: 11460939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
